In cancer, SIRT1 is upregulated during EGF-mediated epithelial-to-mesenchymal transition [91], while in vascular smooth muscle cells, resveratrol, a SIRT1 stimulator, interferes with EGF-induced ROS production [92]. Here, EGF is linked to cancer.